About Suining Central Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Shanghai Henlius Biotech
1
Shanghai Junshi Bioscience Co., Ltd.
1
Sichuan Academy of Medical Sciences
1
Sichuan Cancer Hospital and Research Institute
1
Weidong Ren
1
Zambon SpA
1
Clinical Trials at Suining Central Hospital
During the past decade, Suining Central Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
2012-11-20
2017-06-25
Completed
978
Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC
2018-12-06
2021-03-10
Unknown status
62
A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions
2019-06-25
2021-02-05
Completed
333
Multicenter Normal Reference Study of Tissue Motion Tracking of Mitral Annular Displacement(TMAD)
2020-06-01
2021-09-30
Unknown status
2,400
A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma
2020-10-30
2025-08-14
Active, not recruiting
461
PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer
2022-02-10
2028-07-31
Recruiting
680
A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture
2022-06-17
2024-08-10
Active, not recruiting
478
Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke
2023-01-15
2027-05-31
Not yet recruiting
336
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Suining Central Hospital" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Shanghai Henlius Biotech" with 1 trials
sponsored, "Shanghai Junshi Bioscience Co., Ltd." with 1 trials sponsored, "Sichuan Academy of Medical Sciences" with 1 trials sponsored and "Sichuan Cancer Hospital and Research Institute"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Suining Central Hospital"
#1 collaborator was "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials as a collaborator and "Sichuan Provincial People's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Suining Central Hospital
According to Clinical.Site data, the most researched conditions in "Suining Central Hospital" are
"Abnormal Mucus Secretions" (1 trials), "Acute Ischemic Stroke" (1 trials), "Alteplase" (1 trials), "Basilar Artery Occlusion" (1 trials) and "Endovascular Treatment" (1 trials). Many other conditions were trialed in "Suining Central Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Suining Central Hospital
Most popular intervention types in "Suining Central Hospital" are "Drug" (5 trials), "Biological" (2 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ambroxol hydrochloride 30 mg" (1 trials), "Atezolizumab" (1 trials), "Atezolizumab Matching Placebo" (1 trials), "Cisplatin" (1 trials) and "Echocardiography" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Suining Central Hospital
The vast majority of trials in "Suining Central Hospital" are
7 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Suining Central Hospital
Currently, there are NaN active trials in "Suining Central Hospital".
1 are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Suining Central Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Suining Central Hospital, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".